Crinetics Pharmaceuticals Stock (NASDAQ:CRNX), Quotes and News Summary

Q: What sector and industry does Crinetics Pharmaceuticals (CRNX) operate in?

Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Crinetics Pharmaceuticals Stock (NASDAQ: CRNX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	103.000 / 806.425K
Day Range	- - -
52 Wk Range	15.760 - 49.580
Market Cap	$3.290B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	6.92%
Days to Cover	4.31

Recent News

Endocrine Disease-Focused Crinetics Pharmaceuticals Stock Soars On Tuesday - Here's Why

Crinetics Pharmaceuticals unveils PATHFNDR-2 Phase 3 results for paltusotine in acromegaly treatment. Statistically significant efficacy & safety, with plans for FDA submission in 2024.

Vandana Singh

Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.

Avi Kapoor

National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Crinetics Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, d...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Crinetics Pharmaceuticals (CRNX) stock?

You can purchase shares of Crinetics Pharmaceuticals (NASDAQ: CRNX) through any online brokerage.

View our list of the best stock brokerages.

Who are Crinetics Pharmaceuticals's (CRNX) competitors?

Other companies in Crinetics Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).

What is the target price for Crinetics Pharmaceuticals (CRNX) stock?

The latest price target for Crinetics Pharmaceuticals (NASDAQ: CRNX) was reported by JMP Securities on Thursday, March 28, 2024. The analyst firm set a price target for 80.00 expecting CRNX to rise to within 12 months (a possible 89.48% upside). 38 analyst firms have reported ratings in the last year.

Current Stock Price for Crinetics Pharmaceuticals (CRNX)?

The stock price for Crinetics Pharmaceuticals (NASDAQ: CRNX) is $42.22 last updated April 18, 2024 at 5:33 PM EDT.

Does Crinetics Pharmaceuticals (CRNX) pay a dividend?

There are no upcoming dividends for Crinetics Pharmaceuticals.

When is Crinetics Pharmaceuticals (NASDAQ:CRNX) reporting earnings?

Crinetics Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Is Crinetics Pharmaceuticals (CRNX) going to split?

There is no upcoming split for Crinetics Pharmaceuticals.

What sector and industry does Crinetics Pharmaceuticals (CRNX) operate in?

Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-